Cosmetic or dermatological preparation
The invention relates to a cosmetic or dermatological preparation, comprising: a) one or more chemical light protection filters selected from the group consisting of 2,4,6-Trianilino-p-(carbo-2′-ethylhexyl-1′oxy)-1,3,5-triazine (ethylhexyl triazon), 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)-propane-1,3-dion (butyl methoxydibenzoyl-methane), bisoctyloxyphenol-methoxyphenyl-triazine (bis-ethylhexyloxyphenol methoxyphenyl triazine) and 2-[-4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexylester (diethylamino hydroxybenzoyl hexyl benzoate); and/or one or more light protection filters selected from the group consisting of superficially treated, or untreated, pigments of titanium dioxide or zinc oxide; b) at least one ester of a C8-C16-fatty acid and isoamyl alcohol.
1. A cosmetic or dermatological preparation, characterized by comprising:
a) one or more chemical sun protection filters selected from the group consisting of 2,4,6-trianilino-p-(carbo-2′-ethylhexyl-1′oxy)-1,3,5-triazine (ethylhexyl triazone), 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)-propane-1,3-dion (butyl methoxydibenzoylmethane), bis-octyloxyphenol-methoxyphenyl-triazine (bis-ethylhexyloxyphenol methoxyphenyl triazine) and 2-[-4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexylester (diethylamino hydroxybenzoyl hexyl benzoate); and/or one or more sun protection filters selected from the group consisting of superficially treated, or untreated, pigments of titanium dioxide or zinc oxide, wherein the preparation comprises 2 to 10% of said titanium dioxide or zinc oxide pigments;
b) at least one ester of a C8-C16 fatty acid and isoamyl alcohol.
2. The preparation according to claim 1 , characterized in that the fatty acid is lauric acid.
3. The preparation according to claim 1 , characterized by comprising the ester of a C8-C16 fatty acid and isoamyl alcohol in a concentration of 0.1 to 50%.
4. The preparation according to claim 1 , characterized by comprising the ester of a C8-C16 fatty acid and isoamyl alcohol in a concentration of 0.5 to 20%.
5. The preparation according to claim 1 , characterized by further comprising 2,4,6-trianilino-p-(carbo-2′-ethylhexyl-1′oxy)-1,3,5-triazine (ethylhexyl triazone) in a concentration of 0.1% to 10%.
6. The preparation according to claim 1 , characterized by further comprising 2,4,6-trianilino-p-(carbo-2′-ethylhexyl-1′oxy)-1,3,5-triazine (ethylhexyl triazone) in a concentration of 0.5% to 6.0%.
7. The preparation according to claim 1 , characterized by further comprising 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)-propane-1,3-dion (butyl methoxydibenzoylmethane) in a concentration of 0.1% to 6.0%.
8. The preparation according to claim 1 , characterized by further comprising 1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)-propane-1,3-dion (butyl methoxydibenzoylmethane) in a concentration of 0.5% to 4.0%.
9. The preparation according to claim 1 , characterized by further comprising bis-octyloxyphenol-methoxyphenyl-triazine (bis-ethylhexyloxyphenol methoxyphenyl triazine) in a concentration of 0.1% to 15.0%.
10. The preparation according to claim 1 , characterized by further comprising bis-octyloxyphenol-methoxyphenyl-triazine (bis-ethylhexyloxyphenol methoxyphenyl triazine) in a concentration of 0.5% to 10.0%.
11. The preparation according to claim 1 , characterized by further comprising 2-[-4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexyl ester (diethylamino hydroxybenzoyl hexyl benzoate) in a concentration of 0.1% to 10%.
12. The preparation according to claim 1 , characterized by further comprising 2-[-4-(diethylamino)-2-hydroxybenzoyl]benzoic acid hexyl ester (diethylamino hydroxybenzoyl hexyl benzoate) in a concentration of 0.5 to 6%.